J wave syndromes.

PubWeight™: 3.54‹?› | Rank: Top 1%

🔗 View Article (PMC 2843811)

Published in Heart Rhythm on December 11, 2009

Authors

Charles Antzelevitch1, Gan-Xin Yan

Author Affiliations

1: Masonic Medical Research Laboratory, Utica, New York 13501, USA. ca@mmrl.edu

Articles citing this

Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79

Circadian rhythms govern cardiac repolarization and arrhythmogenesis. Nature (2012) 2.59

Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm (2011) 2.26

The early repolarization pattern in the general population: clinical correlates and heritability. J Am Coll Cardiol (2011) 1.95

Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm (2010) 1.89

Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. Heart Rhythm (2011) 1.87

Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J Am Coll Cardiol (2014) 1.82

Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol (2013) 1.70

Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator. Heart Rhythm (2012) 1.60

Early repolarization syndrome: a decade of progress. J Electrocardiol (2013) 1.59

A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. Heart Rhythm (2011) 1.43

Early repolarisation and J wave syndromes. Indian Heart J (2014) 1.40

Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J (2012) 1.40

Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur Heart J (2011) 1.37

Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. Eur Heart J (2011) 1.29

Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res (2012) 1.25

Short QT syndrome: from bench to bedside. Circ Arrhythm Electrophysiol (2010) 1.21

J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm (2015) 1.14

Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy. Nat Rev Cardiol (2012) 1.04

ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int J Cardiol (2014) 1.04

J wave syndromes: molecular and cellular mechanisms. J Electrocardiol (2013) 1.03

Overview of Basic Mechanisms of Cardiac Arrhythmia. Card Electrophysiol Clin (2011) 0.99

A KCNJ8 mutation associated with early repolarization and atrial fibrillation. Europace (2012) 0.97

Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome. Heart Rhythm (2013) 0.96

Perspective: a dynamics-based classification of ventricular arrhythmias. J Mol Cell Cardiol (2015) 0.95

Case of Recurrent Ventricular Fibrillations with Osborn Wave Developed during Therapeutic Hypothermia. Korean Circ J (2015) 0.94

Early repolarization syndrome: A cause of sudden cardiac death. World J Cardiol (2015) 0.94

Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Hum Mutat (2012) 0.93

J-wave syndromes. from cell to bedside. J Electrocardiol (2011) 0.93

ECG repolarization syndrome abnormalities (J wave syndromes) and idiopathic ventricular fibrillation: diagnostic and management. J Interv Card Electrophysiol (2011) 0.93

Left-to-right ventricular differences in I(KATP) underlie epicardial repolarization gradient during global ischemia. Heart Rhythm (2011) 0.91

Rationale for the use of the terms J-wave syndromes and early repolarization. J Am Coll Cardiol (2011) 0.91

A nonsynonymous polymorphism in semaphorin 3A as a risk factor for human unexplained cardiac arrest with documented ventricular fibrillation. PLoS Genet (2013) 0.89

Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. Circ Arrhythm Electrophysiol (2014) 0.88

Mechanisms of sudden cardiac death. Indian Heart J (2014) 0.88

Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG. Heart Vessels (2014) 0.87

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Heart Rhythm (2016) 0.87

Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects. Curr Probl Cardiol (2015) 0.86

The investigation of sudden arrhythmic death syndrome (SADS)-the current approach to family screening and the future role of genomics and stem cell technology. Front Physiol (2013) 0.86

Ventricular fibrillation associated with early repolarization in a patient with thyroid storm. J Interv Card Electrophysiol (2010) 0.86

Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res (2011) 0.84

Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: a prospective observational study. Clin Res Cardiol (2015) 0.84

J Wave Syndromes: History and Current Controversies. Korean Circ J (2016) 0.83

Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants. J Cardiovasc Electrophysiol (2011) 0.82

Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases (2015) 0.82

Optimal antiarrhythmic drug therapy for electrical storm. J Biomed Res (2015) 0.82

Properties and molecular determinants of the natural flavone acacetin for blocking hKv4.3 channels. PLoS One (2013) 0.81

Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome. Heart Rhythm (2016) 0.80

[Early repolarisation. A dilemma of risk stratification]. Herzschrittmacherther Elektrophysiol (2013) 0.80

Short and long QT syndromes: does QT length really matter? J Electrocardiol (2010) 0.80

Electrocardiographic J waves are associated with right ventricular morphology and function: evaluation by cardiac magnetic resonance imaging. Heart Vessels (2013) 0.79

The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis. Front Physiol (2013) 0.79

Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells. PLoS One (2012) 0.79

Prognostic implications of Q waves and T-wave inversion associated with early repolarization. Mayo Clin Proc (2012) 0.79

The KCNJ8-S422L variant previously associated with J-wave syndromes is found at an increased frequency in Ashkenazi Jews. Eur J Hum Genet (2013) 0.78

Seasonal, weekly, and circadian distribution of ventricular fibrillation in patients with J-wave syndrome from the J-PREVENT registry. J Arrhythm (2015) 0.78

[The ICD as primary prevention. Rare indications]. Herzschrittmacherther Elektrophysiol (2010) 0.78

ST-segment elevation: defined by the company it keeps. Mayo Clin Proc (2012) 0.78

J wave syndromes: a decade of progress. Chin Med J (Engl) (2015) 0.77

A gain-of-function I(K-ATP) mutation and its role in sudden cardiac death associated with J-wave syndromes. Heart Rhythm (2010) 0.77

A case of short-coupled premature ventricular beat-induced ventricular fibrillation with early repolarization in the inferolateral leads. J Arrhythm (2014) 0.77

Genetics of inherited primary arrhythmia disorders. Appl Clin Genet (2015) 0.77

Ventricular fibrillation associated with complete right bundle branch block. Heart Rhythm (2013) 0.77

Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves. Front Physiol (2016) 0.77

Low serum eicosapentaenoic acid level is a risk for ventricular arrhythmia in patients with acute myocardial infarction: a possible link to J-waves. Heart Vessels (2013) 0.77

Notching early repolarization pattern in inferior leads increases risk of ventricular tachyarrhythmias in patients with acute myocardial infarction: a meta-analysis. Sci Rep (2015) 0.76

Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome. Expert Opin Orphan Drugs (2015) 0.76

Brugada Syndrome and Early Repolarisation: Distinct Clinical Entities or Different Phenotypes of the Same Genetic Disease? Arrhythm Electrophysiol Rev (2016) 0.75

J Wave Syndrome: Clinical Diagnosis, Risk Stratification and Treatment. J Atr Fibrillation (2014) 0.75

Giant J (Osborn) Wave due to Bonsai Abuse: Comments on Clinical Practice. Balkan Med J (2017) 0.75

Early Repolarisation - What Should the Clinician Do? Arrhythm Electrophysiol Rev (2015) 0.75

Early Repolarization Syndrome; Mechanistic Theories and Clinical Correlates. Front Physiol (2016) 0.75

Short QT Syndrome - Review of Diagnosis and Treatment. Arrhythm Electrophysiol Rev (2014) 0.75

Local Left Ventricular Epicardial J Waves and Late Potentials in Brugada Syndrome Patients with Inferolateral Early Repolarization Pattern. Front Physiol (2017) 0.75

Calcium Channel Mutations in Cardiac Arrhythmia Syndromes. Curr Mol Pharmacol (2015) 0.75

Where are the T-waves? Europace (2011) 0.75

Out in the cold: the hypothermic heart response. BMJ Case Rep (2014) 0.75

Reply: Takotsubo syndrome and polymorphic ventricular tachycardia: The chicken or the egg. J Arrhythm (2016) 0.75

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. J Arrhythm (2016) 0.75

Diffuse ST segment depression from hypothermia. Int J Emerg Med (2010) 0.75

Atrial arrhythmias in inherited arrhythmogenic disorders. J Arrhythm (2016) 0.75

Congenital long QT syndrome and concomitant early repolarization pattern: a benign association or an ICD-worthy one? Heart Rhythm (2014) 0.75

Premature ventricular beats initiate recurrent ventricular fibrillation in early repolarization syndrome. J Arrhythm (2014) 0.75

A novel mutation in the SCN5A gene contributes to arrhythmogenic characteristics of early repolarization syndrome. Int J Mol Med (2016) 0.75

A study of ECG pattern, cardiac structural abnormalities and familial tendency in patients with early repolarisation syndrome in South India. Heart Asia (2014) 0.75

Combined ECG, Echocardiographic, and Biomarker Criteria for Diagnosing Acute Myocardial Infarction in Out-of-Hospital Cardiac Arrest Patients. Yonsei Med J (2015) 0.75

Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding. Behav Med (2014) 0.75

Early repolarization syndrome- to be or not to be benign. Maedica (Buchar) (2011) 0.75

Brugada Syndrome:Risk Stratification And Management. J Atr Fibrillation (2016) 0.75

A female patient with hypokalaemia-induced J wave syndrome: An unusual case report. Medicine (Baltimore) (2017) 0.75

Different rate-dependent responses between J waves and the notches on an epicardial local electrogram in a patient with idiopathic ventricular fibrillation. HeartRhythm Case Rep (2017) 0.75

Articles cited by this

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol (1992) 12.18

Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76

Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89

Experimental hypothermia; respiratory and blood pH changes in relation to cardiac function. Am J Physiol (1953) 5.63

Cellular basis for the electrocardiographic J wave. Circulation (1996) 5.25

Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation (1999) 5.04

Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med (2009) 4.53

Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37

Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99

Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res (1991) 3.07

J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol (2008) 2.87

The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56

Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. J Electrocardiol (2000) 2.54

Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54

Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation (2007) 2.50

Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res (1988) 2.49

Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol (1996) 2.42

Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol (2008) 2.42

Augmentation of J waves and electrical storms in patients with early repolarization. N Engl J Med (2008) 2.38

Sudden coronary death in women. Am Heart J (1998) 2.33

Spontaneous episode of polymorphic ventricular tachycardia in a patient with intermittent Brugada syndrome. J Cardiovasc Electrophysiol (2001) 2.25

Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat (2003) 2.24

Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation (2002) 2.23

Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21

Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20

The normal RS-T segment elevation variant. Am J Cardiol (1961) 2.16

Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol (2000) 2.08

Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm (2004) 2.07

Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant? J Cardiovasc Electrophysiol (2000) 2.03

I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol (1996) 1.91

A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet (2009) 1.87

Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol (2003) 1.81

Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol (2001) 1.58

Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation (2004) 1.57

Profound hypothermia mimicking a Brugada type ECG. J Electrocardiol (2003) 1.49

Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry? Circulation (1993) 1.38

Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome. Eur Heart J (2009) 1.38

Early repolarization on scalar electrocardiogram. Am J Med Sci (1995) 1.33

Occurrence of "J waves" in 12-lead ECG as a marker of acute ischemia and their cellular basis. Pacing Clin Electrophysiol (2007) 1.28

Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. J Cardiovasc Electrophysiol (2003) 1.20

Ventricular fibrillation causes sudden death in Southeast Asian immigrants. Ann Intern Med (1984) 1.13

Clinical characteristics of patients with spontaneous or inducible ventricular fibrillation without apparent heart disease presenting with J wave and ST segment elevation in inferior leads. J Cardiovasc Electrophysiol (2000) 1.12

Left ventricular septal and apex pacing for optimal pump function in canine hearts. J Am Coll Cardiol (2003) 1.10

ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage. J Electrocardiol (2005) 1.10

Long-term evaluation of early repolarization syndrome (normal variant RS-T segment elevation). Am J Cardiol (1976) 1.09

Brugada syndrome with atypical ECG: downsloping ST-segment elevation in inferior leads. J Electrocardiol (2004) 1.07

Cellular and ionic mechanisms responsible for the Brugada syndrome. J Electrocardiol (2000) 1.05

Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol (2003) 1.05

Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm (2007) 1.04

ECG repolarization waves: their genesis and clinical implications. Ann Noninvasive Electrocardiol (2005) 1.02

Idiopathic ventricular fibrillation and bradycardia-dependent intraventricular block. Am Heart J (1993) 1.01

Bangungut in Manila: sudden and unexplained death in sleep of adult Filipinos. Int J Epidemiol (1998) 1.01

A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med (2004) 1.00

The nonspecific camel-hump sign. JAMA (1976) 0.99

Ischemic J wave: novel risk marker for ventricular fibrillation? Heart Rhythm (2009) 0.92

Prevention of ventricular fibrillation during profound hypothermia by quinidine. Ann Surg (1960) 0.90

Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences. J Electrocardiol (2005) 0.90

Early repolarization syndrome: is it always benign? Int J Cardiol (2006) 0.90

Ventricular fibrillation in a patient with prominent j wave in the inferior and lateral electrocardiographic leads after gastrostomy. Pacing Clin Electrophysiol (2006) 0.89

Sudden, unexpected, nocturnal deaths among Southeast Asian refugees. MMWR Morb Mortal Wkly Rep (1981) 0.87

An attempt at electrical catheter ablation of the arrhythmogenic area in idiopathic ventricular fibrillation. Am Heart J (1992) 0.86

Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Am Heart J (2002) 0.85

Increased dispersion of repolarization time determined by monophasic action potentials in two patients with familial idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol (1998) 0.82

ST segment elevation and sudden cardiac death: from the Brugada syndrome to acute myocardial ischemia. J Cardiovasc Electrophysiol (2000) 0.79

Articles by these authors

Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation (2003) 3.05

Brugada syndrome. Pacing Clin Electrophysiol (2006) 2.61

Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy. Circ Arrhythm Electrophysiol (2009) 2.16

T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol (2008) 2.14

Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias. Heart Rhythm (2006) 2.03

Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome. Circulation (2002) 1.84

L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J Cardiovasc Electrophysiol (2006) 1.57

L-type calcium current recovery versus ventricular repolarization: preserved membrane-stabilizing mechanism for different QT intervals across species. Heart Rhythm (2007) 1.48

Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: a blinded validation. Heart Rhythm (2012) 1.44

Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy. Circ Arrhythm Electrophysiol (2009) 1.43

Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm (2007) 1.23

Short QT syndrome: from bench to bedside. Circ Arrhythm Electrophysiol (2010) 1.21

Dronedarone. Circulation (2009) 1.14

ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage. J Electrocardiol (2005) 1.10

The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertension. J Electrocardiol (2005) 1.06

Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers. Br J Pharmacol (2010) 1.05

In vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarials. Antimicrob Agents Chemother (2012) 1.02

ECG repolarization waves: their genesis and clinical implications. Ann Noninvasive Electrocardiol (2005) 1.02

Ventricular transmural repolarization sequence: its relationship with ventricular relaxation and role in ventricular diastolic function. Eur Heart J (2009) 0.99

Calcium-activated chloride current contributes to action potential alternations in left ventricular hypertrophy rabbit. Am J Physiol Heart Circ Physiol (2008) 0.96

Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes. J Cardiovasc Pharmacol (2011) 0.96

Preclinical assessment of drug-induced proarrhythmias: role of the arterially perfused rabbit left ventricular wedge preparation. Pharmacol Ther (2008) 0.95

A novel mutation in the KCNH2 gene associated with short QT syndrome. J Mol Cell Cardiol (2010) 0.94

Mechanisms underlying arrhythmogenesis in long QT syndrome. J Electrocardiol (2005) 0.94

Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models. J Electrocardiol (2004) 0.93

J-wave syndromes. from cell to bedside. J Electrocardiol (2011) 0.93

Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade. Br J Pharmacol (2011) 0.92

Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. Heart Rhythm (2008) 0.92

Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents. Heart Rhythm (2010) 0.92

Rationale for the use of the terms J-wave syndromes and early repolarization. J Am Coll Cardiol (2011) 0.91

Wenxin Keli suppresses ventricular triggered arrhythmias via selective inhibition of late sodium current. Pacing Clin Electrophysiol (2013) 0.90

A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). J Pharmacol Toxicol Methods (2013) 0.87

A rare cause of 2:1 AV block: long QT syndrome. J Cardiovasc Electrophysiol (2008) 0.87

Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. Ann N Y Acad Sci (2010) 0.86

Brugada syndrome: clinical, genetic, molecular, cellular and ionic aspects. Expert Rev Cardiovasc Ther (2003) 0.86

Vanoxerine: cellular mechanism of a new antiarrhythmic. J Cardiovasc Electrophysiol (2009) 0.86

Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome. Circ Arrhythm Electrophysiol (2013) 0.83

Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. Am J Physiol Heart Circ Physiol (2002) 0.83

Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes. J Cardiovasc Electrophysiol (2005) 0.82

Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm (2009) 0.82

Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias. Am J Physiol Heart Circ Physiol (2010) 0.80

Proarrhythmias and antiarrhythmias: two sides of the same coin. Heart Rhythm (2005) 0.79

The funny current (If): is it a novel antiarrhythmic target to treat atrial fibrillation? J Cardiovasc Electrophysiol (2011) 0.78

Electrocardiographic T wave: a symbol of transmural dispersion of repolarization in the ventricles. J Cardiovasc Electrophysiol (2003) 0.78

Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. Pacing Clin Electrophysiol (2003) 0.78

L539 fs/47, a truncated mutation of human ether-a-go-go-related gene (hERG), decreases hERG ion channel currents in HEK 293 cells. Clin Exp Pharmacol Physiol (2013) 0.78

Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action. J Cardiovasc Pharmacol (2003) 0.77

The J Wave Syndromes and their Role in Sudden Cardiac Death. Card Electrophysiol Clin (2011) 0.76

Pharmacotherapy of cardiac arrhythmias--basic science for clinicians. Pacing Clin Electrophysiol (2009) 0.76

Atrial fibrillation: pharmacological therapy. Curr Probl Cardiol (2011) 0.76

Accurate interpretation of the QT interval: a vital task that remains unaccomplished. Heart Rhythm (2005) 0.75

Inhibition of triggered activities in pulmonary veins: do statins have a direct and clinically relevant antiarrhythmic effect? J Am Coll Cardiol (2011) 0.75

The meta-analysis: supportive or illuminating? Eur Heart J (2006) 0.75

Discarding the baby with the bathwater. Pacing Clin Electrophysiol (2007) 0.75

Making a silk purse out of a sow's ear. J Am Coll Cardiol (2005) 0.75

Instability of type 1 Brugada wave: A more sensitive ECG predictor of cardiac events? Heart Rhythm (2011) 0.75

"Doctor, why didn't you tell me about this before the ICD?". J Cardiovasc Electrophysiol (2006) 0.75

Race and gender equality in health care: are we there yet? Heart Rhythm (2007) 0.75

Born to be bradycardic? Cardiology (2010) 0.75

Evaluation of toxicity for heart failure therapeutics: studying effects on the QT interval. Circ Heart Fail (2010) 0.75

Ischemia versus amiodarone induced polymorphic ventricular tachycardia. Pacing Clin Electrophysiol (2002) 0.75

Two types of T wave alternans in long-QT syndrome. J Cardiovasc Electrophysiol (2014) 0.75

Cardiac metastasis causing right bundle branch block and recurrent septal ventricular tachycardia. J Cardiovasc Electrophysiol (2014) 0.75

Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. Heart Fail Clin (2011) 0.75

Overview of the management of atrial fibrillation: what is the current state of the art? J Cardiovasc Electrophysiol (2003) 0.75